Randomised feasibility trial of the helping families programme-modified: an intensive parenting intervention for parents affected by severe personality difficulties.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
06 02 2020
Historique:
entrez: 9 2 2020
pubmed: 9 2 2020
medline: 16 2 2021
Statut: epublish

Résumé

Specialist parenting intervention could improve coexistent parenting and child mental health difficulties of parents affected by severe personality difficulties. Conduct a feasibility trial of Helping Families Programme-Modified (HFP-M), a specialist parenting intervention. Pragmatic, mixed-methods trial, 1:1 random allocation, assessing feasibility, intervention acceptability and outcome estimates. Two National Health Service health trusts and local authority children's social care. Parents: (i) primary caregiver, (ii) 18 to 65 years, (iii) severe personality difficulties, (iv) proficient English and (v) capacity for consent. Child: (i) 3 to 11 years, (ii) living with index parent and (iii) significant emotional/behavioural difficulties. HFP-M: 16-session home-based intervention using parenting and therapeutic engagement strategies. Usual care: standard care augmented by single psychoeducational parenting session. Primary feasibility outcome: participant retention rate. (i) rates of recruitment, eligibility and data completion, and (ii) rates of intervention acceptance, completion and alliance (Working Alliance Inventory-Short Revised). Primary clinical outcome: child behaviour (Eyberg Child Behaviour Inventory). child mental health (Concerns About My Child, Child Behaviour Checklist-Internalising Scale), parenting (Arnold-O'Leary Parenting Scale, Kansas Parental Satisfaction Scale) and parent mental health (Symptom-Checklist-27). Quantitative data were collected blind to allocation. Findings broadly supported non-diagnostic selection criterion. Of 48 participants recruited, 32 completed post-intervention measures at mean 42 weeks later. Participant retention exceeded a priori rate (HFP-M=18; Usual care=14; 66.7%, 95% CI 51.6% to 79.6%). HFP-M was acceptable, with delivery longer than planned. Usual care had lower alliance rating. Child and parenting outcome effects detected across trial arms with potential HFP-M advantage (effect size range: 0.0 to 1.3). HFP-M is an acceptable and potentially effective specialist parenting intervention. A definitive trial is feasible, subject to consideration of recruitment and retention methods, intervention efficiency and comparator condition. Caution is required in interpretation of results due to reduced sample size. No serious adverse events reported. ISRCTN14573230.

Sections du résumé

BACKGROUND
Specialist parenting intervention could improve coexistent parenting and child mental health difficulties of parents affected by severe personality difficulties.
OBJECTIVE
Conduct a feasibility trial of Helping Families Programme-Modified (HFP-M), a specialist parenting intervention.
DESIGN
Pragmatic, mixed-methods trial, 1:1 random allocation, assessing feasibility, intervention acceptability and outcome estimates.
SETTINGS
Two National Health Service health trusts and local authority children's social care.
PARTICIPANTS
Parents: (i) primary caregiver, (ii) 18 to 65 years, (iii) severe personality difficulties, (iv) proficient English and (v) capacity for consent. Child: (i) 3 to 11 years, (ii) living with index parent and (iii) significant emotional/behavioural difficulties.
INTERVENTION
HFP-M: 16-session home-based intervention using parenting and therapeutic engagement strategies. Usual care: standard care augmented by single psychoeducational parenting session.
OUTCOMES
Primary feasibility outcome: participant retention rate.
SECONDARY OUTCOMES
(i) rates of recruitment, eligibility and data completion, and (ii) rates of intervention acceptance, completion and alliance (Working Alliance Inventory-Short Revised). Primary clinical outcome: child behaviour (Eyberg Child Behaviour Inventory).
SECONDARY OUTCOMES
child mental health (Concerns About My Child, Child Behaviour Checklist-Internalising Scale), parenting (Arnold-O'Leary Parenting Scale, Kansas Parental Satisfaction Scale) and parent mental health (Symptom-Checklist-27). Quantitative data were collected blind to allocation.
RESULTS
Findings broadly supported non-diagnostic selection criterion. Of 48 participants recruited, 32 completed post-intervention measures at mean 42 weeks later. Participant retention exceeded a priori rate (HFP-M=18; Usual care=14; 66.7%, 95% CI 51.6% to 79.6%). HFP-M was acceptable, with delivery longer than planned. Usual care had lower alliance rating. Child and parenting outcome effects detected across trial arms with potential HFP-M advantage (effect size range: 0.0 to 1.3).
CONCLUSION
HFP-M is an acceptable and potentially effective specialist parenting intervention. A definitive trial is feasible, subject to consideration of recruitment and retention methods, intervention efficiency and comparator condition. Caution is required in interpretation of results due to reduced sample size. No serious adverse events reported.
TRIAL REGISTRATION NUMBER
ISRCTN14573230.

Identifiants

pubmed: 32034024
pii: bmjopen-2019-033637
doi: 10.1136/bmjopen-2019-033637
pmc: PMC7045220
doi:

Banques de données

ISRCTN
['ISRCTN14573230']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e033637

Subventions

Organisme : Department of Health
ID : 12/194/01
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: CD is the lead developer of two parenting programmes used in this report: Helping Families Programme and Empowering Parents Empowering Communities. MJC has previously received research grant funding on behalf of Imperial College London from the National Institute for Health Research. LH is a co-developer of the Helping Families Programme. MM was an author of the Psychoeducation plus Problems Solving (PEPS) intervention for adults with personality disorder. PEPS helped to inform the modified HFP. PM reports personal fees from a talk given at Fourth Bergen International Conference on Forensic Psychiatry 2016, Outside of the submitted work. PM led the development of the SAPAS, the personality disorder screen used in this study.

Références

BMJ Open. 2020 Feb 6;10(2):e033637
pubmed: 32034024
Stat Med. 1995 Sep 15;14(17):1933-40
pubmed: 8532986
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
J Consult Clin Psychol. 1999 Jun;67(3):308-19
pubmed: 10369051
Clin Psychol Rev. 2016 Jul;47:85-105
pubmed: 27261413
Clin Psychol Rev. 2006 Jan;26(1):86-104
pubmed: 16280191
Contemp Clin Trials Commun. 2017 Dec;8:67-74
pubmed: 29214229
Aust N Z J Psychiatry. 2007 Jul;41(7):598-605
pubmed: 17558622
Br J Psychiatry. 2000 Aug;177:138-43
pubmed: 11026953
Br J Psychiatry. 2003 Sep;183:228-32
pubmed: 12948996
Evid Based Ment Health. 2015 Aug;18(3):67-75
pubmed: 26205740
Clin Child Fam Psychol Rev. 2013 Mar;16(1):18-34
pubmed: 23420407
J Child Psychol Psychiatry. 2006 Jan;47(1):99-111
pubmed: 16405646
Trials. 2013 Oct 25;14:353
pubmed: 24160371
J Appl Behav Anal. 1980 Summer;13(2):259-73
pubmed: 7380752
J Child Psychol Psychiatry. 2000 Jul;41(5):645-55
pubmed: 10946756
Aust N Z J Psychiatry. 2008 Jul;42(7):572-7
pubmed: 18612860
J Child Psychol Psychiatry. 2005 Aug;46(8):837-49
pubmed: 16033632
Acta Psychiatr Scand. 2011 May;123(5):327-38
pubmed: 21166785
Res Nurs Health. 2008 Apr;31(2):180-91
pubmed: 18183564
Br J Psychiatry. 2006 May;188:423-31
pubmed: 16648528
Trials. 2011 Aug 24;12:198
pubmed: 21864370
J Psychiatr Pract. 2018 Sep;24(5):331-340
pubmed: 30427820
Aust N Z J Psychiatry. 2018 Oct;52(10):949-961
pubmed: 30091375
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Psychiatry. 2006 Winter;69(4):336-50
pubmed: 17326728
Br J Psychiatry. 2006 Jun;188:547-53
pubmed: 16738345
BMC Psychiatry. 2018 May 25;18(1):152
pubmed: 29801441
Curr Opin Psychiatry. 2017 Jul;30(4):283-299
pubmed: 28505032
Pilot Feasibility Stud. 2016 Oct 21;2:64
pubmed: 27965879
Ethics Behav. 2008;18(2-3):234-246
pubmed: 22235163
Clin Psychol Rev. 2015 Aug;40:57-65
pubmed: 26067572
Soc Psychiatry Psychiatr Epidemiol. 2010 Apr;45(4):453-60
pubmed: 19543844
BMJ. 2012 Mar 13;344:e1107
pubmed: 22416059
Qual Life Res. 2010 Aug;19(6):875-86
pubmed: 20405245
Contemp Clin Trials. 2010 Jan;31(1):22-6
pubmed: 19758579
J Subst Abuse Treat. 2007 Jun;32(4):381-90
pubmed: 17481461
Clin Psychol Rev. 2010 Apr;30(3):277-87
pubmed: 20047783

Auteurs

Crispin Day (C)

Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK crispin.1.day@kcl.ac.uk.
Centre for Parent and Child Support, South London and Maudsley NHS Foundation Trust, London, UK.

Jackie Briskman (J)

Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.

Mike J Crawford (MJ)

The Centre for Psychiatry, Imperial College, London, UK.

Lisa Foote (L)

McPin Foundation, London, UK.

Lucy Harris (L)

Centre for Parent and Child Support, South London and Maudsley NHS Foundation Trust, London, UK.

Janet Boadu (J)

King's Health Economics, P024 David Goldberg Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Paul McCrone (P)

King's Health Economics, P024 David Goldberg Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Centre for Mental Health, Institute for Lifecourse Development, University of Greenwich, London, UK.

Mary McMurran (M)

Institute of Mental Health, University of Nottingham, Nottingham, UK.

Daniel Michelson (D)

School of Psychology, University of Sussex, Brighton, UK.

Paul Moran (P)

Department of Population Health Sciences, Centre for Academic Mental Health, University of Bristol, Bristol, UK.

Liberty Mosse (L)

Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.

Stephen Scott (S)

Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Daniel Stahl (D)

Department of Biostatistics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Paul Ramchandani (P)

Faculty of Education, PEDAL Research Centre, University of Cambridge, Cambridge, UK.

Tim Weaver (T)

Department of Mental Health, Middlesex University, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH